Gronghui APP was informed that according to the latest equity disclosure information of the Stock Exchange, on June 27th, 2022, East Rui Pharmaceutical (02348.HK) was increased by non-executive director Liang Kangmin to hold 500000 shares at an average price of HK $1.2833 per share, involving a capital of about HK $641650.
After the increase, Liang Kangmin's latest number of shares is 107112000 shares, with the proportion of shares rising from 7.11% to 7.15%.